These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 1676170)

  • 21. Place conditioning with dopamine D1 and D2 agonists injected peripherally or into nucleus accumbens.
    White NM; Packard MG; Hiroi N
    Psychopharmacology (Berl); 1991; 103(2):271-6. PubMed ID: 1674160
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Acute reduction of dopamine levels alters responses of basal ganglia neurons to selective D-1 and D-2 dopamine receptor stimulation.
    Carlson JH; Bergstrom DA; Demo SD; Walters JR
    Eur J Pharmacol; 1988 Aug; 152(3):289-300. PubMed ID: 2906003
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The role of dopamine in reinforcement: changes in reinforcement sensitivity induced by D1-type, D2-type, and nonselective dopamine receptor agonists.
    Bratcher NA; Farmer-Dougan V; Dougan JD; Heidenreich BA; Garris PA
    J Exp Anal Behav; 2005 Nov; 84(3):371-99. PubMed ID: 16596971
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Is stimulation of both D1 and D2 receptors necessary for the expression of dopamine-mediated behaviors?
    White FJ; Bednarz LM; Wachtel SR; Hjorth S; Brooderson RJ
    Pharmacol Biochem Behav; 1988 May; 30(1):189-93. PubMed ID: 2902644
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prior D1 dopamine receptor stimulation is required to prime D2-mediated striatal Fos expression in 6-hydroxydopamine-lesioned rats.
    Pollack AE; Yates TM
    Neuroscience; 1999; 94(2):505-14. PubMed ID: 10579212
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dopamine D1 receptor involvement in the discriminative-stimulus effects of SKF 81297 in squirrel monkeys.
    Rosenzweig-Lipson S; Bergman J
    J Pharmacol Exp Ther; 1993 Nov; 267(2):765-75. PubMed ID: 7902432
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of dopaminergic drugs on working and reference memory in rats.
    Bushnell PJ; Levin ED
    Pharmacol Biochem Behav; 1993 Aug; 45(4):765-76. PubMed ID: 8105486
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Potency and efficacy of dopamine agonists in mouse strains differing in dopamine cell and receptor number.
    Shannon HE; Bemis KG; Peters SC
    Pharmacol Biochem Behav; 1991 Sep; 40(1):103-7. PubMed ID: 1685781
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ontogeny of nigrostriatal dopamine neuron autoreceptors: iontophoretic studies.
    Wang L; Pitts DK
    J Pharmacol Exp Ther; 1995 Jan; 272(1):164-76. PubMed ID: 7815330
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Activation of both dopamine D1 and D2 receptors necessary for amelioration of conditioned fear stress.
    Kamei H; Kameyama T; Nabeshima T
    Eur J Pharmacol; 1995 Feb; 273(3):229-33. PubMed ID: 7737329
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Caffeine cross-tolerance to selective dopamine D1 and D2 receptor agonists but not to their synergistic interaction.
    Garrett BE; Holtzman SG
    Eur J Pharmacol; 1994 Sep; 262(1-2):65-75. PubMed ID: 7813580
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A D2 dopamine receptor agonist disrupts sensorimotor gating in rats. Implications for dopaminergic abnormalities in schizophrenia.
    Peng RY; Mansbach RS; Braff DL; Geyer MA
    Neuropsychopharmacology; 1990 Jun; 3(3):211-8. PubMed ID: 2141986
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Apomorphine-induced penile erection and yawning: site of action in brain.
    Melis MR; Argiolas A; Gessa GL
    Brain Res; 1987 Jul; 415(1):98-104. PubMed ID: 3497688
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Differential effects of dopamine receptor subtype-specific agonists with respect to operant behavior maintained on a differential reinforcement of low-rate responding (DRL) schedule.
    Chiang FK; Cheng RK; Liao RM
    Pharmacol Biochem Behav; 2015 Mar; 130():67-76. PubMed ID: 25584855
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Stimulation of both D1 and D2 dopamine receptors increases behavioral activation and ascorbate release in the neostriatum of freely moving rats.
    Pierce RC; Rebec GV
    Eur J Pharmacol; 1990 Dec; 191(3):295-302. PubMed ID: 1982267
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of dopamine agonists on delayed response performance in chronic low-dose MPTP-treated monkeys.
    Schneider JS; Sun ZQ; Roeltgen DP
    Pharmacol Biochem Behav; 1994 May; 48(1):235-40. PubMed ID: 7913226
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The role of D1 and D2 dopamine receptors in oral stereotypy induced by dopaminergic stimulation of the ventrolateral striatum.
    Delfs JM; Kelley AE
    Neuroscience; 1990; 39(1):59-67. PubMed ID: 1982467
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Role of the substantia nigra in the expression of dopamine D1 receptor-mediated and D2 receptor-mediated behaviours.
    Fletcher GH; Starr MS
    Neuroscience; 1987 Dec; 23(3):1001-10. PubMed ID: 2963970
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Determination of extracellular glutamate after local K+ stimulation in the striatum of non-anaesthetised rats after treatment with dopaminergic drugs--studies using microdialysis.
    Dietze S; Kuschinsky K
    J Neural Transm Gen Sect; 1992; 90(1):1-11. PubMed ID: 1361342
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The effects of selective dopamine D1 or D2 receptor antagonists on the establishment of agonist-induced place conditioning in rats.
    Hoffman DC; Beninger RJ
    Pharmacol Biochem Behav; 1989 Jun; 33(2):273-9. PubMed ID: 2573075
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.